Sistemas de soporte hepático artificial: estado actual del tratamiento con diálisis de albúmina (MARS)

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Gastroenterología y Hepatología

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1157/13078996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

  2008cited by this paper
• First Use of the Molecular Adsorbent Recirculating System Technique on Patients with Hypoxic Liver Failure After Cardiogenic Shock

  2004cited by this paper
• Extracorporeal Albumin Dialysis: A Procedure for Prolonged Relief of Intractable Pruritus in Patients with Primary Biliary Cirrhosis

  2004cited by this paper
• Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis

  2004cited by this paper
• PROSPECTS FOR EXTRACORPOREAL LIVER SUPPORT

  2004cited by this paper
• Molecular adsorbent recirculating system for acute and acute‐on‐chronic liver failure: A meta‐analysis

  2004cited by this paper
• Pathophysiological effects of albumin dialysis in acute‐on‐chronic liver failure: A randomized controlled study

  2004cited by this paper
• Molecular adsorbent recirculating system in dealing with maternal Amanita poisoning during the second pregnancy trimester: a case report.

  2004cited by this paper
• 174 Experiences with MARS therapy in liver disease: analysis of 385 patients of the international MARS registry

  2003cited by this paper
• Toxicidad hepática por ingesta de setas: curso clínico y nuevas perspectivas de tratamiento

  2003cited by this paper
• Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial

  2003cited by this paper
• Treatment of Phenytoin Toxicity by the Molecular Adsorbents Recirculating System (MARS)

  2003cited by this paper
• Effect of molecular adsorbent recirculating system in hepatitis C virus‐related intractable pruritus

  2003cited by this paper
• Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure

  2003cited by this paper
• Experience with albumin dialysis in five patients with severe overdoses of paracetamol

  2003cited by this paper
• Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis.

  2003cited by this paper
• Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.

  2003cited by this paper
• Use of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication.

  2002cited by this paper
• Extracorporeal albumin dialysis in acute‐on‐chronic liver failure: Will it stand the test of time?

  2002cited by this paper
• MARS: optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning--a case report.

  2002cited by this paper
• Prospects for the temporary treatment of acute liver failure.

  2002cited by this paper
• Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease

  2002cited by this paper
• Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study

  2002cited by this paper
• Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH).

  2001cited by this paper
• Use of MARS in the treatment of acute liver failure: preliminar monocentric experience.

  2001cited by this paper
• Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.

  2001cited by this paper
• Advances in bioartificial liver devices

  2001cited by this paper
• Albumin dialysis using the molecular adsorbent recirculating system

  2001cited by this paper
• Mars in decompensated alcoholic liver disease with multi-organ failure.

  2001cited by this paper
• Treatment of split-liver recipients with poor graft function by albumin-dialysis (mars)

  2001cited by this paper
• Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC).

  2001cited by this paper
• Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system.

  2001cited by this paper
• Molecular adsorbant recirculating system in patients with liver failure.

  2001cited by this paper
• Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients.

  2001cited by this paper
• Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.

  2001cited by this paper
• Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure

  2001cited by this paper
• First experience in Spain with MARS in three patients with advanced liver failure.

  2001cited by this paper
• A model to predict survival in patients with end‐stage liver disease

  2001cited by this paper
• Motor cortex excitability in severe liver failure: effects of Molecular Adsorbent Recycling System

  2001cited by this paper
• Improvement of systemic vascular resistance and arterial pressure in patients with acute on chronic liver failure during treatment with the molecular adsorbent recycling system (mars)

  2001cited by this paper
• One year experience with MARS-Therapy in patients with multiple organ failure in Cardiac Center Bad Oeynhausen

  2001cited by this paper
• Efficacy of MARS in 3 patients with Hepatorenal symdrome and hepatic encephalopathy: first experience in Spain

  2001cited by this paper
• MARS for Treatment of Fulminant Wilson Crisis

  2001cited by this paper
• Employment of MARS (Molecular Adsorbent Recycling System) for replacement of liver detoxification function up to orthotopic liver transplantation

  2001cited by this paper
• Role of Molecular Adsorbent Recycling System (MARS) in the treatment of patients with acute exacerbation of chronic liver failure

  2001cited by this paper
• Albumin dialysis with the M.A.R.S. (Molecular Absorbent Recirculating System) for a patient with acute liver failure due to paracetamol intoxication: A case-report

  2001cited by this paper
• Use of MARS in the Treatment of Acute Liver Failure: Preliminary Monocentric Experience

  2001cited by this paper
• New extracorporeal liver support for chronic liver disease complicated by cholestasis-results of a prospective controlled randomized two center trial

  2001cited by this paper
• Application of Artificial Liver Support (MARS) after split-liver transplantation in an infant

  2001cited by this paper
• Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure

  2001cited by this paper
• Liver support by extracorporeal blood purification: A clinical observation

  2000cited by this paper
• Alternatives to liver transplantation: from hepatocyte transplantation to tissue-engineered organs.

  2000cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• Is there life on Mars?

  1999cited by this paper
• Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins.

  1999cited by this paper
• Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis.

  1999cited by this paper
• Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.

  1999cited by this paper
• A Carrier-Mediated Transport of Toxins in a Hybrid Membrane. Safety Barrier between a Patients Blood and a Bioartificial Liver

  1996cited by this paper
• Liver Transplantation in Europe for Patients with Acute Liver Failure

  1996cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

  1996cited by this paper
• A new procedure for the removal of protein bound drugs and toxins.

  1993cited by this paper

• Large‐Scale Formation and Long‐Term Culture of Hepatocyte Organoids From Streamlined In Vivo Genome‐Edited GGTA1−/− Pigs for Bioartificial Liver Applications

  2024cites this paper
• Scale-up and Economic Assessment of Biofunctional Particles Synthesis for Bilirubin Removal

  2023cites this paper
• Crosslinked Bifunctional Particles for the Removal of Bilirubin in Hyperbilirubinemia Cases

  2023cites this paper
• Development of an automated liver perfusion system: The benefit of a hemofilter

  2018cites this paper
• Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver

  2016cites this paper
• Sistemas de soporte hepático extracorpóreo

  2011cites this paper
• Management of hepatic encephalopathy in children

  2010cites this paper
• [Acute on chronic liver failure].

  2010cites this paper
• Nuevas estrategias terapéuticas en el fallo hepático agudo

  2009cites this paper
• Revisión actualizada sobre la insuficiencia hepática crónica: estudio de un caso

  2008cites this paper
• Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS).

  2006cites this paper